Burning Rock Biotech Ltd (BNR): Total Assets

Annual figures by period end, from SEC filings.

820.38M CNY
As of 2025-12-31
-19.8%
3-year compound annual growth
-21.0%
5-year compound annual growth
2.66B CNY2019-12-31: 847.56M CNY2020-12-31: 2.66B CNY2021-12-31: 2.28B CNY2022-12-31: 1.59B CNY2023-12-31: 1.04B CNY2024-12-31: 885.30M CNY2025-12-31: 820.38M CNY820.38M CNY
2019-12-31 Total Assets (CNY) 2025-12-31
Period endedTotal AssetsChange YoYSource filing
2025-12-31820.38M CNY-7.3%2026-04-28, Balance as of period end
2024-12-31885.30M CNY-14.9%2026-04-28, Balance as of period end
2023-12-311.04B CNY-34.5%2025-04-29, Balance as of period end
2022-12-311.59B CNY-30.3%2024-04-29, Balance as of period end
2021-12-312.28B CNY-14.4%2023-04-20, Balance as of period end
2020-12-312.66B CNY+214.2%2022-04-29, Balance as of period end
2019-12-31847.56M CNYn/a2021-03-23, Balance as of period end

Total Assets at similar companies

Companies with the same SEC industry code (Services-Medical Laboratories), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedTotal AssetsChange YoY
Burning Rock Biotech Ltd (BNR)2025-12-31820.38M CNY-7.3%
Concord Medical Services Holdings Ltd (CCM)2025-12-316.55B CNY-2.7%

Compare BNR, CCM side by side · Screen every company in Services-Medical Laboratories ↗